SCHEMBL3173569

SCHEMBL3173569

[CH2]/C=C/CN(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1329682 1.00
SCHEMBL21065774 0.97
SCHEMBL235759 0.78 KDM4E (0.36)
SCHEMBL317785 0.78 KDM4E (0.36)
Ammonia Solution, Strong SCHEMBL9748105 0.74 KDM4E (0.34)
Hydrochloric Acid SCHEMBL10694337 0.74 KDM4E (0.34)
Hydrochloric Acid SCHEMBL10694332 0.74 KDM4E (0.34)
SCHEMBL16594875 0.72
SCHEMBL16489723 0.69 KDM4E (0.32)
SCHEMBL698664 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101203494-A Process for the synthesis of substituted 3-cyanoquinolines and intermediates thereof WYETH CORP (US) 2008-06-18 CN claimed
EP-1883631-A1 METHODS OF SYNTHESIZING SUBSTITUTED 3-CYANOQUINOLINES AND INTERMEDIATES THEREOF Wyeth (US) 2008-02-06 EP claimed
WO-2006127207-A1 METHODS OF SYNTHESIZING SUBSTITUTED 3-CYANOQUINOLINES AND INTERMEDIATES THEREOF WYETH (US) 2006-11-30 WO claimed
US-20060270668-A1 Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof WYETH (US) 2006-11-30 US claimed
CN-113105475-B Inhibitors of bruton's tyrosine kinase and methods of use thereof 詹森药业有限公司 2022-09-09 CN disclosed
US-RE41253-E1 Antineoplastic combinations WYETH (US) 2010-04-20 US disclosed
US-RE41084-E1 Antineoplastic combinations WYETH (US) 2010-01-19 US disclosed
WO-2009007390-A2 2-PYRAZ INYLBENZ IMIDAZOLE DERIVATIVES AS RECEPTOR TYROSINE KINASE INHIBITORS ASTRAZENECA AB (SE) 2009-01-15 WO disclosed
US-RE40418-E1 Treatment of neoplasms with CCI-779/EKB-569 combination WYETH (US) 2008-07-01 US disclosed
CN-101203494-A Process for the synthesis of substituted 3-cyanoquinolines and intermediates thereof WYETH CORP (US) 2008-06-18 CN disclosed
EP-1883631-A1 METHODS OF SYNTHESIZING SUBSTITUTED 3-CYANOQUINOLINES AND INTERMEDIATES THEREOF Wyeth (US) 2008-02-06 EP disclosed
WO-2006127207-A1 METHODS OF SYNTHESIZING SUBSTITUTED 3-CYANOQUINOLINES AND INTERMEDIATES THEREOF WYETH (US) 2006-11-30 WO disclosed
US-20060270668-A1 Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof WYETH (US) 2006-11-30 US disclosed
EP-1671943-A1 Preparation of EKB-569 and related intermediates Wyeth (US) 2006-06-21 EP disclosed
EP-1414438-B1 ANTINEOPLASTIC COMBINATIONS WYETH CORP (US) 2005-12-28 EP disclosed
EP-1414438-A1 ANTINEOPLASTIC COMBINATIONS Wyeth (US) 2004-05-06 EP disclosed
US-6617333-B2 Rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methyl propionic acid (CCI-779) and 4-dimethylamino-but-2-enoic acid(4-(3-chloro-4-fluoro-phenylamino)-3-cyano-7-ethoxy-quinol in-6-yl)amide (EKB-569); synergistic; antitumor agents WYETH 2003-09-09 US disclosed
WO-2003020266-A1 ANTINEOPLASTIC COMBINATIONS WYETH (US) 2003-03-13 WO disclosed
US-20030050222-A1 Antineoplastic combinations WYETH 2003-03-13 US disclosed
EP-0216299-A1 Quinoxaline derivatives, method for their preparartion and their use to protect cultivated plants against phytotoxical reaction of herbicides BASF Aktiengesellschaft (DE) 1987-04-01 EP disclosed